Multiple myeloma is a cancer of your plasma cells, a type of white blood cell present in your bone marrow. It is a highly manageable disease that has seen rapid medical advancements in the past few years. Myeloma is usually diagnosed after a series of blood tests and a bone marrow biopsy.
Learn from experts about myeloma clinical trials and the multitude of treatment options and targeted therapies. Keep up-to-date with the latest information.
Upcoming EventsSee all events
Thursday, October 22, 2020
One of the backbones of the myeloma treatment regimen is lenalidomide (Revlimid). But what happens when a myeloma patient becomes resistant to this widely used oral drug? Join us for our next multiple myeloma Answers Now program on Thursday, October 22 at 2:30 pm PT/5:30 pm ET.